BeStock  
Markets › Compare › PHAT vs STTK

PHAT vs STTK

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PHAT · Phathom Pharmaceuticals$4.66 ▼ 8.27%
STTK · Shattuck Labs$4.46 ▼ 1.98%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

10111211312413Nov 24, '25May 26, '26Nov 20, '26
  • PHAT -68.6%
  • STTK +116.5%

Head to head

MetricPHATSTTK
Price$4.66$4.46
Change today▼ 8.27%▼ 1.98%
Market cap$378.82M$454.22M
Return, 3 months-46.2%-43.5%
Return, year to date-71.9%+22.2%
Return, 1 year-68.9%+119.7%
P/E (TTM)––
P/B-1.12.3
P/E percentile vs own 5y4th10th
Dividend yield––
Revenue growth (YoY, latest qtr)+71.1%-100.0%
Net profit growth (YoY)+53.6%-150.6%
Gross margin80.7%–
Operating margin-9.3%–
Net margin-30.2%–
Return on equity–-47.2%
Analyst target vs. price+262.7%+242.8%
Analyst buy share83%100%
RSI (14)3135
30-day volatility98.0%73.9%
Max drawdown, 1 year-74.2%-50.5%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • STTK is the largest of the group by market value.
  • STTK has returned the most over the past year.
  • PHAT is growing revenue fastest.
  • STTK has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top